AVCR Avricore Health

Avricore Health Announces $1.5 Million Financing

Avricore Health Announces $1.5 Million Financing
EN
14/10/2020

Underlying

AVCRAvricore Health

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Avricore Health

 PRESS RELEASE
Free
AVCR AVRICORE HEALTH

Avricore Grants Options

Avricore Grants Options VANCOUVER, British Columbia, June 14, 2025 (GLOBE NEWSWIRE) -- AVRICORE HEALTH INC. (TSXV: AVCR) (the "Company" or “Avricore”) today announces that the Company’s board of directors has approved the granting of stock options (the “Options”) exercisable for a total of 4,100,000 common shares to its directors, officers, employees and consultants at an exercise price of CAD $0.05 per common share. All Options were granted pursuant to the Company’s stock option plan and are subject to the terms of the applicable grant agreements and the requirements of the TSX Ventur...

June 14, 2025 1 EN
 PRESS RELEASE
Free
AVCR AVRICORE HEALTH

Avricore Appoints Rodger Seccombe as CEO

Avricore Appoints Rodger Seccombe as CEO VANCOUVER, British Columbia, June 05, 2025 (GLOBE NEWSWIRE) -- AVRICORE HEALTH INC. (TSXV: AVCR) (the "Company" or “Avricore”) is pleased to report the appointment of Rodger Seccombe as CEO of the Company. Mr. Seccombe currently serves as Chief Technology Officer of Avricore and is the President and Co-Founder of its wholly owned subsidiary, HealthTab™ Inc. David Hall, Chairman of the board stated, “In his role as Avricore’s CTO Rodger has been instrumental in the development of the Company’s flagship HealthTab platform. We are excited to have Rod...

June 5, 2025 1 EN
 PRESS RELEASE
Free
AVCR AVRICORE HEALTH

AVRICORE HEALTH CORPORATE UPDATE: Q1 Results and Ongoing Progress Repo...

AVRICORE HEALTH CORPORATE UPDATE: Q1 Results and Ongoing Progress Report VANCOUVER, British Columbia, June 02, 2025 (GLOBE NEWSWIRE) -- AVRICORE HEALTH INC. (TSXV: AVCR) (the “Company” or “Avricore”) reports on its result for the first quarter of 2025 and its progress towards expansion objectives for the balance of the year. For the three months ended March 31, 2025 the Company realized revenues of $434,061 with a gross profit of $346,297. The Company recorded a comprehensive loss of $77,300 with a net increase in cash of $137,068. Plan the Work – Work the Plan The Company is currently...

June 2, 2025 1 EN
 PRESS RELEASE
Free
AVCR AVRICORE HEALTH

AVRICORE HEALTH CORPORATE UPDATE: 2024 record year, UK expansion on tr...

AVRICORE HEALTH CORPORATE UPDATE: 2024 record year, UK expansion on track VANCOUVER, British Columbia, May 01, 2025 (GLOBE NEWSWIRE) -- AVRICORE HEALTH INC. (TSXV: AVCR) (the "Company" or “Avricore”) reports on its year end 2024 and In the year ended December 31, 2024 revenue increased by 37% year over year to $4,785,711 and gross profit increased by 56% to $1,880,306.In the three months ended December 31, 2024 revenue increased by 5% year over year to $1,421,076 and gross profit increased by 18% to $589,930. “Launching and expanding HealthTab™ in North East ...

May 1, 2025 1 EN
 PRESS RELEASE
Free
AVCR AVRICORE HEALTH

HealthTab™ and Patients Know Best® Bring Pharmacy-Based Blood Test Res...

HealthTab™ and Patients Know Best® Bring Pharmacy-Based Blood Test Results to Millions in UK VANCOUVER, British Columbia, Jan. 29, 2025 (GLOBE NEWSWIRE) -- Avricore Health Inc. (TSXV: AVCR, OTC: AVCRF) (“Avricore Health” or the “Company”) today announced its successful integration of HealthTab™ the Company’s cloud-connected, pharmacy-based platform for testing and health data management, with Patients Know Best (PKB), the UK’s leading patient personal health record (PHR). The new partnership enables a seamless connection between real-time diagnostic results from pharmacy point-of...

January 29, 2025 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch